Skip to content
DataLookout
Menu

NCT06926062

Interpersonal Communication Training and Vaccination Workflow Training Alone and in Combination to Improve Communication and Recommendations About HPV Vaccination in Pharmacies, IMPACT HPV Trial

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 12 versions: 11 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Start date pushed from Oct 15, 2026 to Dec 1, 2026
  2. Notable Start date: Sep 1, 2026 to Oct 15, 2026 Show 4 more changesShow less
    • Eligibility criteria expanded, about 7 words
    • Secondary endpoints: details revised at 7 of 8 entries
    • Site details revised at 1 of 2 sites
    • Collaborators: details revised at 1 of 1 entry
  3. Notable Recruitment opened
    • Site details revised at 2 of 2 sites
    v10
  4. Notable Primary completion pushed from Sep 1, 2026 to Aug 1, 2027
    • Start date: Jun 1, 2026 to Sep 1, 2026
    • Study completion pushed from Oct 1, 2027 to Dec 1, 2027
    v9
  5. Notable Start date: Mar 1, 2026 to Jun 1, 2026v8
Show 5 earlier versionsHide 5 earlier versions
  1. Notable Start date: Dec 1, 2025 to Mar 1, 2026v6
  2. Notable Start date: Sep 1, 2025 to Dec 1, 2025v5
  3. Notable Start date: Aug 1, 2025 to Sep 1, 2025v4
  4. Notable Primary completion date: Aug 1, 2025 to Sep 1, 2026
    • Start date: Jul 1, 2025 to Aug 1, 2025
    • Study completion date: Oct 1, 2026 to Oct 1, 2027
    v3
  5. Notable Start date: Jun 1, 2025 to Jul 1, 2025v2
  1. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Perceived fit, relevance, or compatibility of human papillomavirus (HPV) vaccination or the communication strategy for a given practice site, provider, or patient (Appropriateness: Pharmacy Staff)
Timeframe: At baseline, 2 months post-training delivery, and 12 months post-training delivery
Perceived fit, relevance, or compatibility of human papillomavirus (HPV) vaccination or the communication strategy for a given practice site, provider, or patient (Appropriateness: Parents)
Timeframe: The outcome will be measured at one time point, at a time frame from the date of vaccine administration to up to 8 weeks after that vaccine administration date
Perceptions that HPV vaccinations or the communication strategy is agreeable, palatable, or satisfactory (Acceptability: Pharmacy Staff)
Timeframe: At baseline, 2 months post-training delivery, and 12 months post-training delivery
Perceptions that HPV vaccinations or the communication strategy is agreeable, palatable, or satisfactory (Acceptability: Parents)
Timeframe: The outcome will be measured at one time point, at a time frame from the date of vaccine administration to up to 8 weeks after that vaccine administration date
Extent to which the communication strategy was successfully implemented and used at pharmacies to support HPV vaccine delivery (Feasibility)
Timeframe: At baseline, 2 months post-training delivery, and 12 months post-training delivery
HPV vaccination delivery (Fidelity: Pharmacy Staff)
Timeframe: Up to completion of the 12 month trial period
HPV vaccination delivery (Fidelity: Parents)
Timeframe: The outcome will be measured at one time point, at a time frame from the date of vaccine administration to up to 8 weeks after that vaccine administration date
Self-efficacy
Timeframe: At baseline, 2 months post-training delivery, and 12 months post-training delivery

Secondary (8)

Service penetration/effectiveness
Adoption
Reach
Outer context/setting
Inner context/setting
Show 3 moreShow less
Implementation process domain
Innovation factors/characteristics
Individuals' domain

Arms and interventions

Objective 1, Topic I (safety and side effects survey)Other

Parents review 4 messages on safety and side effects and complete a survey over 15-20 minutes in support of intervention refinement on study.

Objective 1, Topic II (vaccine effectiveness survey)Other

Parents review 4 messages on vaccine effectiveness and complete a survey over 15-20 minutes in support of intervention refinement on study.

Objective 1, Topic III (sexual activity survey)Other

Parents review 4 messages on sexual activity and complete a survey over 15-20 minutes in support of intervention refinement on study.

Objective 1, Topic IV (HPV vaccine for boys survey)Other

Parents review 4 messages on HPV vaccine for boys and complete a survey over 15-20 minutes in support of intervention refinement on study.

Objective 1, Topic V (age to start vaccine survey)Other

Parents review 4 messages on age to start vaccine and complete a survey over 15-20 minutes in support of intervention refinement on study.

Objective 1, Topic VI (school entry requirements survey)Other

Parents review 4 messages on school entry requirements and complete a survey over 15-20 minutes in support of intervention refinement on study.

Objective 2, Group I (control)Active comparator

Pharmacy staff provide vaccinations per usual care.

Objective 2, Group II (strategy A)Experimental

Pharmacy staff receive interpersonal communication training over 120 minutes and provide vaccinations using the interpersonal communication strategy.

Objective 2, Group III (strategy B)Experimental

Pharmacy staff receive the vaccination workflow training and provide vaccinations using the vaccination workflow training strategy.

Objective 2, Group IV (strategies A and B)Experimental

Pharmacy staff receive interpersonal communication training as well as vaccination workflow training and provide vaccinations using both the interpersonal communication strategy and the vaccination workflow training strategy.

Other: Best Practice, Educational Intervention, Interview, Questionnaire Administration

Behavioral: Training and Education

Procedures: Vaccination

Sites

2 sites in 1 country